TORONTO–(BUSINESS WIRE)–NEO is pleased to welcome Vancouver-based Filament Health Corp. (“Filament”), an exclusively-natural psychedelic drug discovery and extraction technology company, to the NEO Exchange. Filament began trading today under the symbol FH. With a robust and innovative IP portfolio, accomplished management team, in-house GMP manufacturing capabilities, and a Health Canada…


Previous articleMydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004
Next articleAlbert Labs Announces a Distinguished Clinical and Scientific Advisory Board